Headquartered in Tokyo, Japan, Takeda Pharmaceuticals dates back to 1781. From its beginnings selling traditional medicines to its more recent stance at the forefront of medicinal advancement, Takeda exists to create better health for people and a brighter future for the world.
The science and technology Takeda advances concentrate in the vanguard of pharmaceutical innovation. Their expertise spans gastrointestinal issues, inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Believing a healthier planet makes for healthier people, Takeda designs its sustainability strategy with public health in mind. Highlights include:
-
The decision to transition from a carbon neutrality goal to a net-zero emissions goal (with decarbonization targets set for 2035 for operational emissions and 2040 for the value chain)
-
Resource management: Takeda aims to reduce its energy consumption, shift to renewable resources, and collaborate on hard-to-abate emissions such as single-use plastics and disposal of regulated medical waste
-
Carbon removal: Takeda prioritizes high-quality, nature-based projects that benefit human health
We’re excited to work with Takeda to advance its decarbonization goals. Learn more about its work on pharmaceuticals and decarbonization in its 2024 Annual Integrated Report.
